Medical News

RSS

$Osteoblast cell injections accelerate fracture healing$

Osteoblast cell injections accelerate fracture healing

Long bone fractures heal faster after injections of bone-building cells.

11 Feb 2009

Bristol Neuroscientists host brain workshops

Around 100 local pupils will have the chance to take part in some really ‘brainy' activities this week at a series of interactive workshops, hosted by Bristol University neuroscientists, to help them discover more about the science of the brain.

11 Feb 2009

Bone marrow transplant patients may benefit from new immune research

Bone marrow transplant (BMT) researchers at The Medical College of Wisconsin Cancer Center in Milwaukee may have found a mechanism that could preserve the leukemia-killing effects of a transplant graft, while limiting the damage donor immune cells might do to the recipient host's vital organs.

11 Feb 2009

New self-sanitizing antibacterial plaster

Scientists in China are reporting development and testing of new self-sanitizing plaster with more powerful antibacterial effects than penicillin.

11 Feb 2009

Abbott receives FDA clearance for new CELL-DYN Emerald hematology instrument

Abbott has announced it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its new, compact hematology instrument, CELL-DYN Emerald.

11 Feb 2009

A new method to detect presence of 23 illicit drugs

A team of scientists from the Institute of Legal Medicine at the University of Santiago de Compostela (USC) has developed a technique for detecting the presence of 23 illicit drugs and medicines in saliva samples.

11 Feb 2009

2 genes influence social behavior, visual-spatial performance in people with Williams syndrome

Unraveling the genetics of social behavior and cognitive abilities, researchers at the University of Utah and the Salk Institute for Biological Studies have traced the role of two genes,GTF2I and GTF2IRD, in a rare genetic disorder known as Williams Syndrome.

11 Feb 2009

ViroPharma reports results of trial for Maribavir in bone marrow transplant patients

ViroPharma Incorporated has announced that its Phase 3 trial evaluating maribavir used as prophylaxis in allogeneic stem cell, or bone marrow, transplant (SCT) patients did not achieve its primary endpoint.

10 Feb 2009

Lots of exercise may help prevent vision loss

There's another reason to dust off those running shoes. Vigorous exercise may help prevent vision loss, according to a pair of studies from the U.S. Department of Energy's Lawrence Berkeley National Laboratory.

10 Feb 2009

Sundia MediTech and Xcovery announce new drug discovery

Sundia MediTech, a CRO company based in Shanghai, China and Xcovery, a company based in Florida, U.S.A. jointly announced their 2 year collaborative success in new drug discovery at IBC's BioProcess International Conference yesterday in San Diego, USA.

10 Feb 2009

Genetic risk for substance use can be neutralized by good parenting

A genetic risk factor that increases the likelihood that youth will engage in substance use can be neutralized by high levels of involved and supportive parenting, according to a new University of Georgia study.

10 Feb 2009

Fluid buildup in lungs is part of the damage done by the flu

In a fight against respiratory infections, the body typically produces a little fluid to help the lungs generate a productive cough.

10 Feb 2009

Race and ethnicity affect use of hospice services among patients with advanced cancer

Race and ethnicity appear to have an effect on whether a patient with terminal cancer uses hospice care services, according to a study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).

10 Feb 2009

Researchers identify mutation that causes inflammatory bowel disease

A team of scientists at The Scripps Research Institute has linked a mouse mutation to an increased susceptibility for developing inflammatory bowel disease -- represented in humans as Crohn's disease and ulcerative colitis, which together are estimated to affect more than a million people in the United States.

10 Feb 2009

Roche commences tender offer for Genentech

Roche announced today that it is commencing a cash tender offer for all outstanding publicly-held shares of Genentech for US$86.50 per share.

10 Feb 2009

Rituximab maintenance therapy improves survival in patients with relapsed follicular lymphoma

atients with relapsed or refractory follicular lymphoma who continue on maintenance rituximab therapy after chemotherapy have better overall survival than patients who do not receive this treatment, according to a meta-analysis of randomized trials in the February 10 online issue of the Journal of the National Cancer Institute.

10 Feb 2009

Program for kidney disease patients effective for reducing serum phosphorus levels

Patients with end-stage renal disease (ESRD) who participated in an education program to limit their intake of phosphorus-containing food additives lowered their blood levels of the chemical, according to a study in the February 11 issue of JAMA, the Journal of the American Medical Association.

10 Feb 2009

Postnatal psychosis more common in older first-time mothers

Women who give birth for the first time after the age of 35 run a greater risk than younger first-time mothers of suffering a psychosis in the months after delivery.

10 Feb 2009

Obesity during pregnancy associated with increased risk of birth defects

For women who are obese during pregnancy there is an associated increased risk of certain birth defects, such as spina bifida and neural tube defects, although the absolute increase in risk is likely to be small, according to an analysis of previous studies, reported in the February 11 issue of JAMA.

10 Feb 2009

Costs of digestive diseases grown to more than $141 billion a year

Digestive, liver and pancreatic diseases result in more than 100 million outpatient visits and 13 million hospitalizations annually at a cost of $141.8 billion.

10 Feb 2009